×
About 77,860 results

ALLMedicine™ Cirrhosis Center

Research & Reviews  36,527 results

Aggressive primary gastric lymphoma (PGL) masquerading as hepatocellular cancer (HCC) i...
https://doi.org/10.1186/s12876-021-01691-y 10.1158/1055-9965.EPI-06-1056 10.1093/oxfordjournals.annonc.a058465 10.1182/blood-2005-06-2508 10.1038/bjc.2011.450 10.1097/00004836-200104000-00023 10.1007/BF02934095 10.3892/ol.2014.2657 10.1136/bmjgast-2019-000320 10.1200/JCO.2013.54.8800 10.1155/2017/2397430 10.1016/0016-5085(91)90063-Q
BMC Gastroenterology; Ahmed M, Al-Khazraji A et. al.

Mar 5th, 2021 - The gastrointestinal tract is sa well-known site for extranodal Non-Hodgkin lymphomas, with the stomach is known to be the most common site on lymphoma, primary gastric lymphoma (PGL). The lymphoproliferative disorder rarely occurs in patients wit...

Intrahepatic cholangiocarcinoma in a non-cirrhotic liver in a patient with homozygous Z...
https://doi.org/10.1136/bcr-2020-240077
BMJ Case Reports; Vuurberg NE, Van den Boom AL et. al.

Mar 4th, 2021 - Alpha-1 antitrypsin (AAT) deficiency, which is an under-recognised metabolic genetic disorder, is known to cause severe lung disease and liver cirrhosis in about 10%-15% of cases. Patients with AAT deficiency are at a higher risk for developing he...

Exercise Only Works If You Do It! The Holy Grail of Adherence.
https://doi.org/10.14309/ajg.0000000000001198
The American Journal of Gastroenterology; Kok B, McNeely M et. al.

Mar 4th, 2021 - Exercise interventions in patients with cirrhosis have been shown to improve muscle mass and strength, aerobic capacity, fatigue, and quality of life. There are gaps, however, including limited data on patients with decompensated cirrhosis and hom...

Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban ...
https://doi.org/10.14309/ajg.0000000000001195
The American Journal of Gastroenterology; Wong RJ, Jain MK et. al.

Mar 4th, 2021 - To evaluate the impact of chronic hepatitis B virus infection (CHB) treatment on risk of cirrhosis, liver-related outcomes, and death among a diverse CHB cohort with a large proportion of African Americans. Adults with noncirrhotic CHB without hum...

Novel Application of Predictive Modeling: A Tailored Approach to Promoting HCC Surveill...
https://doi.org/10.1016/j.cgh.2021.02.038
Clinical Gastroenterology and Hepatology : the Official C... Singal AG, Chen Y et. al.

Mar 4th, 2021 - There has been increased interest in interventions to promote hepatocellular carcinoma (HCC) surveillance given low utilization and high proportions of late stage detection. Accurate prediction of patients likely versus unlikely to respond to inte...

see more →

Guidelines  113 results

Fibrosis regression after eradication of hepatitis C virus - from bench to bedside.
https://doi.org/10.1053/j.gastro.2020.09.065
Gastroenterology Rockey DC, Friedman SL

Feb 2nd, 2021 - Hepatitis C virus (HCV) infection and its complications have been the major cause of cirrhosis and its complications for several decades in the Western world. Until recently, treatment for HCV with interferon-based regimens was associated with mod...

Chemical Risk Factors of Primary Liver Cancer: An Update
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801911/
Hepatic Medicine: Evidence and Research; Barsouk A, Thandra KC et. al.

Jan 4th, 2021 - Primary liver cancer has the sixth highest incidence and fourth highest cancer mortality worldwide. Hepatitis B is the leading cause of liver cancer, though its incidence is decreasing with vaccination. Alcohol is the leading cause of liver transp...

AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review.
https://doi.org/10.1016/j.cgh.2020.10.034
Clinical Gastroenterology and Hepatology : the Official C... Patton H, Heimbach J et. al.

Jan 4th, 2021 - AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review.|2021|Patton H,Heimbach J,McCullough A,|

AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achie...
https://doi.org/10.1053/j.gastro.2020.11.051
Gastroenterology Younossi ZM, Corey KE et. al.

Dec 11th, 2020 - Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease, with global public health impact affecting more than 25% of the global population. NAFLD is associated with significant morbidity and mortality from cirrhosis, h...

AGA Clinical Practice Update on Palliative Care Management in Cirrhosis: Expert Review.
https://doi.org/10.1016/j.cgh.2020.11.027
Clinical Gastroenterology and Hepatology : the Official C... Tandon P, Walling A et. al.

Nov 22nd, 2020 - Care with palliative care principles (aka Palliative Care, PC) is an approach to care that focuses on improving the quality of life of patients and their caregivers who are facing life-limiting illness. It encompasses the assessment and management...

see more →

Drugs  885 results see all →

Clinicaltrials.gov  38,593 results

Aggressive primary gastric lymphoma (PGL) masquerading as hepatocellular cancer (HCC) i...
https://doi.org/10.1186/s12876-021-01691-y 10.1158/1055-9965.EPI-06-1056 10.1093/oxfordjournals.annonc.a058465 10.1182/blood-2005-06-2508 10.1038/bjc.2011.450 10.1097/00004836-200104000-00023 10.1007/BF02934095 10.3892/ol.2014.2657 10.1136/bmjgast-2019-000320 10.1200/JCO.2013.54.8800 10.1155/2017/2397430 10.1016/0016-5085(91)90063-Q
BMC Gastroenterology; Ahmed M, Al-Khazraji A et. al.

Mar 5th, 2021 - The gastrointestinal tract is sa well-known site for extranodal Non-Hodgkin lymphomas, with the stomach is known to be the most common site on lymphoma, primary gastric lymphoma (PGL). The lymphoproliferative disorder rarely occurs in patients wit...

Intrahepatic cholangiocarcinoma in a non-cirrhotic liver in a patient with homozygous Z...
https://doi.org/10.1136/bcr-2020-240077
BMJ Case Reports; Vuurberg NE, Van den Boom AL et. al.

Mar 4th, 2021 - Alpha-1 antitrypsin (AAT) deficiency, which is an under-recognised metabolic genetic disorder, is known to cause severe lung disease and liver cirrhosis in about 10%-15% of cases. Patients with AAT deficiency are at a higher risk for developing he...

Exercise Only Works If You Do It! The Holy Grail of Adherence.
https://doi.org/10.14309/ajg.0000000000001198
The American Journal of Gastroenterology; Kok B, McNeely M et. al.

Mar 4th, 2021 - Exercise interventions in patients with cirrhosis have been shown to improve muscle mass and strength, aerobic capacity, fatigue, and quality of life. There are gaps, however, including limited data on patients with decompensated cirrhosis and hom...

Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban ...
https://doi.org/10.14309/ajg.0000000000001195
The American Journal of Gastroenterology; Wong RJ, Jain MK et. al.

Mar 4th, 2021 - To evaluate the impact of chronic hepatitis B virus infection (CHB) treatment on risk of cirrhosis, liver-related outcomes, and death among a diverse CHB cohort with a large proportion of African Americans. Adults with noncirrhotic CHB without hum...

Novel Application of Predictive Modeling: A Tailored Approach to Promoting HCC Surveill...
https://doi.org/10.1016/j.cgh.2021.02.038
Clinical Gastroenterology and Hepatology : the Official C... Singal AG, Chen Y et. al.

Mar 4th, 2021 - There has been increased interest in interventions to promote hepatocellular carcinoma (HCC) surveillance given low utilization and high proportions of late stage detection. Accurate prediction of patients likely versus unlikely to respond to inte...

see more →

News  1,665 results

Terlipressin Shows Benefit in Hepatorenal Syndrome but Risks Spark Concern
https://www.medscape.com/viewarticle/946833

Mar 3rd, 2021 - NEW YORK (Reuters Health) - Details of the phase-3 CONFIRM trial show the vasopressin analog terlipressin can reverse the effects of type 1 hepatorenal syndrome (HRS-1), although not without potentially serious side effects. The study, published i...

Study Questions Albumin Use in Decompensated Cirrhosis
https://www.medscape.com/viewarticle/946828

Mar 3rd, 2021 - NEW YORK (Reuters Health) - A large new phase-3 study is questioning the widespread use of albumin to treat deadly decompensated cirrhosis, especially when the long-trusted therapy may pose a risk of significant side effects. Dr. Alastair O'Brien ...

New AASLD Guidelines Ask Us to Reconsider How We View Bleeding Risk in Cirrhosis
https://www.medscape.com/viewarticle/946425

Mar 3rd, 2021 - This transcript has been edited for clarity. Hello. I'm Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia. Kudos to the American Association for the Study of Liver Disease...

Algorithm Uses Routine Blood Tests to Detect Advanced Liver Disease
https://www.medscape.com/viewarticle/946198

Feb 22nd, 2021 - NEW YORK (Reuters Health) - It may be possible to pick up occult liver cirrhosis with an algorithm that uses data from routine blood tests, according to new research. The CIRRUS algorithm can find "a fingerprint for cirrhosis in the common blood t...

AGA Clinical Practice Update: Bariatric Surgery in Patients With Cirrhosis
https://www.medscape.com/viewarticle/945465

Feb 7th, 2021 - Obesity, a risk factor for nonalcoholic fatty liver disease (NAFLD) and a prevalent comorbidity among people with cirrhosis of all etiologies, is associated with a number of untoward health outcomes, and weight loss is an important goal, according...

see more →

Patient Education  77 results see all →